The influence of the GALT in TSE agent neuroinvasion from the large intestine
GALT对TSE剂大肠神经侵袭的影响
基本信息
- 批准号:BB/G003947/1
- 负责人:
- 金额:$ 44.64万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2009
- 资助国家:英国
- 起止时间:2009 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Transmissible spongiform encephalophathies (TSEs) are prolonged diseases which cause extensive damage to nerves in the brain. In the absence of a cure TSE diseases are invariably fatal. These diseases affect both animals and humans, and include Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform encephalopathy in cattle, chronic wasting disease in mule deer and elk, and scrapie in sheep and goats. Some animal species and humans have become infected with these diseases after eating TSE agent-contaminated food, or through transplantation of TSE agent-contaminated tissues or tissue products (eg: transfusion of blood from a variant CJD-infected donor). Many questions remain concerning the route the infectious TSE agent takes from the site of exposure (eg: intestine) to the brain where it causes damage to nerve cells. We have shown that soon after exposure TSE agents first target and accumulate within lymphoid tissues (Peyer's patches in the small intestine, lymph nodes and spleen) before they spread to the brain. Many TSE agents must accumulate in these lymphoid tissues before they can subsequently spread to the brain (a process termed neuroinvasion) where they ultimately cause neurodegeneration and death. After oral exposure TSE agents also accumulate within lymphoid tissues in the large intestine such as the appendix. However, the contribution of the large intestine to oral TSE pathogenesis is unknown and has been mostly overlooked. This is unfortunate as the large intestine may be an important early site of TSE agent accumulation that influences disease susceptibility. For example, inflammation or pathology within the large intestine may affect disease susceptibility. In the current project, mice will be created that contain lymphoid tissues in the large intestine only. These mice will be used to test the hypothesis that lymphoid tissues in the large intestine are important sites of TSE agent accumulation which influence disease pathogenesis and susceptibility. To achieve this, the following measurable objectives will be addressed: Objective 1- Characterise the development and status of the lymphoid tissues within the small and large intestines Objective 2- Determine the influence of lymphoid tissues in TSE agent neuroinvasion from the large intestine Finally, the effects that other intestinal pathogens may have on TSE susceptibility are not known. For example, the pathology that these pathogens cause in the intestine may increase the uptake of the TSE agent, whereas an influx of inflammatory cells may destroy the TSE agent reducing susceptibility. In Objective 3 the effects of infection with a common gut parasite on oral TSE pathogenesis will be determined. These data will provide predictions on how infection with gastrointestinal pathogens may influence TSE susceptibility. Objective 3- Determine the influence of infection with a gastrointestinal pathogen on oral TSE pathogenesis Currently, effective therapeutics and prophylactics to treat TSE diseases are lacking. Furthermore, no reliable preclinical diagnostic test is available. A thorough understanding of the early events in TSE pathogenesis will aid the determination of risk, the development of pre-clinical diagnostics and therapeutics, especially the development TSE-specific mucosal vaccines.
传染性海绵状脑病(tse)是一种对大脑神经造成广泛损害的长期性疾病。在没有治疗方法的情况下,TSE疾病总是致命的。这些疾病对动物和人类都有影响,包括人类的克雅氏病(CJD)、牛的牛海绵状脑病、骡子鹿和麋鹿的慢性消耗性疾病以及绵羊和山羊的痒病。一些动物物种和人类在食用了被TSE物质污染的食物后,或通过移植被TSE物质污染的组织或组织产品(例如:输入感染了变型cjd的供者的血液)感染了这些疾病。关于传染性TSE病原体从暴露部位(如肠道)到大脑的途径,它对神经细胞造成损害,仍然存在许多问题。我们的研究表明,暴露后不久,TSE病原体首先靶向并在淋巴组织内积聚(小肠、淋巴结和脾脏的Peyer’s斑块),然后扩散到大脑。许多TSE因子必须在这些淋巴组织中积累,然后才能扩散到大脑(这一过程称为神经侵袭),最终导致神经变性和死亡。经口接触后,TSE病原体也会在大肠的淋巴组织(如阑尾)内积累。然而,大肠在口腔TSE发病机制中的作用尚不清楚,而且大多被忽视。这是不幸的,因为大肠可能是影响疾病易感性的TSE病原体积累的重要早期部位。例如,大肠内的炎症或病理可能影响疾病的易感性。在目前的项目中,将培育出只在大肠中含有淋巴组织的小鼠。这些小鼠将用于验证大肠淋巴组织是影响疾病发病机制和易感性的重要TSE药物蓄积部位的假设。为了实现这一目标,将解决以下可测量的目标:目标1-描述小肠和大肠内淋巴组织的发育和状态目标2-确定淋巴组织对大肠TSE病原体神经侵袭的影响最后,其他肠道病原体可能对TSE易感性的影响尚不清楚。例如,这些病原体在肠道中引起的病理可能会增加TSE剂的摄取,而炎症细胞的涌入可能会破坏TSE剂,从而降低易感性。目的3将确定一种常见肠道寄生虫感染对口腔TSE发病机制的影响。这些数据将为胃肠道病原体感染如何影响TSE易感性提供预测。目的3-确定胃肠道病原体感染对口腔TSE发病机制的影响。目前,缺乏有效的治疗和预防措施来治疗TSE疾病。此外,没有可靠的临床前诊断测试。深入了解TSE发病机制的早期事件将有助于确定风险,开发临床前诊断和治疗方法,特别是开发TSE特异性粘膜疫苗。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Differential regulation of small intestinal and colonic lymphoid tissue development by IL-23 and regulatory T cells
IL-23 和调节性 T 细胞对小肠和结肠淋巴组织发育的差异调节
- DOI:
- 发表时间:2012
- 期刊:
- 影响因子:6.4
- 作者:Donaldson, D.S.
- 通讯作者:Donaldson, D.S.
The development of isolated lymphoid follicles in the large intestine
大肠中孤立淋巴滤泡的发育
- DOI:
- 发表时间:2010
- 期刊:
- 影响因子:6.4
- 作者:Donaldson, D.S.
- 通讯作者:Donaldson, D.S.
Regulation of colonic isolated lymphoid follicle development by IL-25 and IL-23
IL-25 和 IL-23 对结肠离体淋巴滤泡发育的调节
- DOI:
- 发表时间:2013
- 期刊:
- 影响因子:6.4
- 作者:Donaldson D.S
- 通讯作者:Donaldson D.S
Reciprocal regulation of lymphoid tissue development in the large intestine by IL-25 and IL-23.
- DOI:10.1038/mi.2014.90
- 发表时间:2015-05
- 期刊:
- 影响因子:8
- 作者:
- 通讯作者:
The Gut-Associated Lymphoid Tissues in the Small Intestine, Not the Large Intestine, Play a Major Role in Oral Prion Disease Pathogenesis.
- DOI:10.1128/jvi.01544-15
- 发表时间:2015-09
- 期刊:
- 影响因子:5.4
- 作者:Donaldson DS;Else KJ;Mabbott NA
- 通讯作者:Mabbott NA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Neil Mabbott其他文献
Neil Mabbott的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Neil Mabbott', 18)}}的其他基金
Role of IFNGR1 in reactive astrocyte activation
IFNGR1 在反应性星形胶质细胞激活中的作用
- 批准号:
BB/V006444/1 - 财政年份:2021
- 资助金额:
$ 44.64万 - 项目类别:
Research Grant
Role of distinct mononuclear phagocyte subsets in oral prion disease pathogenesis
不同的单核吞噬细胞亚群在口腔朊病毒病发病机制中的作用
- 批准号:
BB/S005471/1 - 财政年份:2019
- 资助金额:
$ 44.64万 - 项目类别:
Research Grant
Japan Partnering Award: Defining the factors that regulate M cell-development in the intestines of livestock species
日本合作奖:确定调节家畜肠道 M 细胞发育的因素
- 批准号:
BB/S019294/1 - 财政年份:2019
- 资助金额:
$ 44.64万 - 项目类别:
Research Grant
Determining the role of CSF1R-dependent macrophages in of Paneth cells and the intestinal stem cell niche
确定 CSF1R 依赖性巨噬细胞在潘氏细胞和肠道干细胞生态位中的作用
- 批准号:
MR/S000763/1 - 财政年份:2018
- 资助金额:
$ 44.64万 - 项目类别:
Research Grant
UK-Japan partnership to explore the role of subepithelial mesenchymal stromal cells in M cell-development and homeostasis
英日合作探索上皮下间充质基质细胞在 M 细胞发育和稳态中的作用
- 批准号:
BB/R012377/1 - 财政年份:2017
- 资助金额:
$ 44.64万 - 项目类别:
Research Grant
Determining the effects of ageing on the innate mucosal immune system
确定衰老对先天粘膜免疫系统的影响
- 批准号:
BB/M024288/1 - 财政年份:2015
- 资助金额:
$ 44.64万 - 项目类别:
Research Grant
Determining the effects of aging on the splenic marginal zone and the implications for host immunity
确定衰老对脾边缘区的影响及其对宿主免疫的影响
- 批准号:
BB/L007452/1 - 财政年份:2014
- 资助金额:
$ 44.64万 - 项目类别:
Research Grant
US-A transatlantic partnership to identify novel factors that influence the development and function of M cells in the gut epithelium
美国-跨大西洋合作伙伴关系,以确定影响肠道上皮 M 细胞发育和功能的新因素
- 批准号:
BB/K021257/1 - 财政年份:2013
- 资助金额:
$ 44.64万 - 项目类别:
Research Grant
Determining the role of M cells in TSE agent neuroinvasion from the intestine
确定 M 细胞在 TSE 制剂肠道神经侵袭中的作用
- 批准号:
BB/J014672/1 - 财政年份:2012
- 资助金额:
$ 44.64万 - 项目类别:
Research Grant
Determining the role of CXCR5-expressing dendritic cells in immune function and TSE agent neuroinvasion from the intestine
确定表达 CXCR5 的树突状细胞在免疫功能和来自肠道的 TSE 剂神经侵袭中的作用
- 批准号:
BB/F019726/1 - 财政年份:2009
- 资助金额:
$ 44.64万 - 项目类别:
Research Grant
相似国自然基金
METTL3介导的ASB16上调促进C1GALT1降解在IgA肾病中的作用和机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:青年科学基金项目
糖基转移酶B3GALT4调控神经母细胞瘤CD8+T细胞耗竭的作用及机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
幽门螺旋杆菌通过调控胃上皮细胞B4GALT5表达介导糖基化修饰促进胃癌进展的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
氨诱导C1GALT1调控星形胶质细胞钙稳态的机制研究
- 批准号:32301064
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠上皮b3galt5通过抑制CCL5分泌缓解肠炎的机制研究。
- 批准号:82300590
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
B4GalT5通过调控CD36糖基化修饰水平影响代谢相关脂肪性肝病的机制研究
- 批准号:2023J01320
- 批准年份:2023
- 资助金额:9.0 万元
- 项目类别:省市级项目
B4GALT1基因通过促进轻链N-连接糖基化生成致淀粉样变轻链的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
circSDHAF2通过B4GALT1介导ITGA5糖基化修饰在GBM间充质样转化和抑制性免疫微环境形成中的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
C1GALT1 促进T 抗原合成增加参与胃癌转移的分子机制研究
- 批准号:2022JJ30511
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
m6A介导的TRIM21上调促进C1GALT1降解在IgAN发生发展中的作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
相似海外基金
Elucidation of molecular basis of GALT formation using novel Peyer's patch deficient mice
使用新型派尔氏集结缺陷小鼠阐明 GALT 形成的分子基础
- 批准号:
22H02822 - 财政年份:2022
- 资助金额:
$ 44.64万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A targeted anti-HIV drug delivery to the GALT
向 GALT 输送靶向抗 HIV 药物
- 批准号:
10218032 - 财政年份:2020
- 资助金额:
$ 44.64万 - 项目类别:
A targeted anti-HIV drug delivery to the GALT
向 GALT 输送靶向抗 HIV 药物
- 批准号:
10082955 - 财政年份:2020
- 资助金额:
$ 44.64万 - 项目类别:
A targeted anti-HIV drug delivery to the GALT
向 GALT 输送靶向抗 HIV 药物
- 批准号:
10431955 - 财政年份:2020
- 资助金额:
$ 44.64万 - 项目类别:
A targeted anti-HIV drug delivery to the GALT
向 GALT 输送靶向抗 HIV 药物
- 批准号:
10680418 - 财政年份:2020
- 资助金额:
$ 44.64万 - 项目类别:
Clostridium difficile Immunity: Role of IGA and GALT
艰难梭菌免疫:IGA 和 GALT 的作用
- 批准号:
8871101 - 财政年份:2015
- 资助金额:
$ 44.64万 - 项目类别:
HIV-1 Reservoir in Gut-Associated Lymphoid Tissue (GALT) in Primary HIV Infection
原发性 HIV 感染中肠道相关淋巴组织 (GALT) 中的 HIV-1 储库
- 批准号:
MR/N001265/1 - 财政年份:2015
- 资助金额:
$ 44.64万 - 项目类别:
Fellowship
Clostridium difficile Immunity: Role of IGA and GALT
艰难梭菌免疫:IGA 和 GALT 的作用
- 批准号:
9068835 - 财政年份:2015
- 资助金额:
$ 44.64万 - 项目类别: